Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2020-03-21 2020-03-20
Drug Identification Number 02245522 02245522
Brand name TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05% TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%
Common or Proper name TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05% TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%
Company Name TARO PHARMACEUTICALS INC TARO PHARMACEUTICALS INC
Ingredients CLOBETASOL PROPIONATE CLOBETASOL PROPIONATE
Strength(s) 0.05% 0.05%
Dosage form(s) SOLUTION SOLUTION
Route of administration TOPICAL TOPICAL
Packaging size 60 ml 60 ml
ATC code D07AD D07AD
ATC description CORTICOSTEROIDS, PLAIN CORTICOSTEROIDS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-03-20 2020-03-20
Estimated end date 2020-03-27 2020-03-27
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments